With a new president and a new Congress, it's time for Medicare drug price negotiation

20 January 2021 - Since passage of the Medicare Modernization Act in 2003, which prohibited Medicare from negotiating prescription drug prices, ...

Read more →

Changes to Medicare Advantage and Part D will provide better coverage, more access and improved transparency for Medicare beneficiaries

15 January 2021 - Today, the CMS issued a final rule that further advances the agency’s efforts to strengthen and modernise ...

Read more →

TLV wants to go further with combination treatments in the field of cancer

7 December 2020 - Part of the solution for more patients to have access to combination treatments may be to create ...

Read more →

Trump Administration announces prescription drug payment model to put American patients first

20 November 2020 - In support of President Trump’s historic commitment to lowering drug prices for American patients, HHS Secretary Alex ...

Read more →

Trump officials preparing to move forward with major step to lower Medicare drug prices

16 November 2020 - The Trump administration is preparing to move forward with a major proposal to lower drug prices, ...

Read more →

CMS takes steps to ensure Medicare beneficiaries have wide access to COVID-19 antibody treatment

10 November 2020 - Coverage available at no cost to beneficiaries across variety of settings in health care system. ...

Read more →

2021 Medicare Part B Premiums Remain Steady

6 November 2020 - Today, the Centers for Medicare & Medicaid Services announced the 2021 monthly Medicare Parts A and B ...

Read more →

IQWiG publishes a new version of its general methods

5 November 2020 - New features include the investigation of volume-outcome relationships and different mean observation times in clinical studies. ...

Read more →

2021 Federal Health Insurance Exchange open enrolment period starts on 1 November on HealthCare.gov

30 October 2020 - CMS is announcing that the open enrolment period for the Federal Health Insurance Exchange will officially ...

Read more →

Medicare and Medicaid to cover early COVID-19 vaccine

26 October 2020 - The new regulations would allow beneficiaries to receive a vaccine under “emergency authorisation” at no cost. ...

Read more →

Top Democrats call for watchdog to review Trump Medicare drug cards

13 October 2020 - Top-ranking Democrats want an independent watchdog to expedite a review of the Trump administration's plans to ...

Read more →

Inventiva receives FDA breakthrough therapy designation for lead drug candidate lanifibranor in NASH

12 October 2020 - Inventiva today announced that the U.S. FDA has granted breakthrough therapy designation to lanifibranor, the Company’s lead ...

Read more →

Real world evidence from a narrow therapeutic index product (levothyroxine) reflects the therapeutic equivalence of generic drug product

5 October 2020 - The National Institute of Diabetes and Digestive and Kidney Diseases reports that almost 5% of the U.S. ...

Read more →

Innova Therapeutics receives rare paediatric disease designation from the FDA for IVT-8086 for the treatment of osteosarcoma

24 September 2020 - Innova Therapeutics Inc., a biopharmaceutical company committed to developing innovative cancer therapies for patients who have inadequate ...

Read more →

Medicare wouldn’t cover costs of administering coronavirus vaccine approved under Emergency Use Authorisation

21 September 2020 - Trump administration officials are exploring options to quickly fix plan to make the vaccine free for all ...

Read more →